Merck to collaborate with Tempus AI on precision oncology
Source: SeekingAlpha
2026-03-03 10:23:37 ET
More on Merck
- Health Care Q4 Dividend Roundup: Merck Offers Thicker Dividend Cushion Than AbbVie
- Merck: Why Investors Should Remain Bullish Despite Patent Risks
- Merck: Keytruda Remains Resilient Despite LOE Risks - Buy Upon Correction
- CDC acting director calls for measles vaccination
- Merck's Keytruda shows overall survival benefit in ovarian cancer
Read the full article on Seeking Alpha
For further details see:
Merck to collaborate with Tempus AI on precision oncology
Tempus AI Inc.
NASDAQ: TEM
TEM Trading
-0.28% G/L:
$50.12 Last:
3,258,304 Volume:
$51.44 Open:
TEM Latest News
March 11, 2026 08:30:00 am
Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings
March 03, 2026 12:19:00 pm
Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve Outcomes
March 03, 2026 08:30:00 am
Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine
TEM Stock Data
$9,941,457,633
111,547,851
0.08%
177
N/A
Healthcare Providers & Services
Healthcare
US
Chicago
